Pfizer Inc. Share Price & Technical Analysis

PFE · $25.90 (-0.19%)

Healthcare / Drug Manufacturers - General

AI Score 29 · Bearish

$25.90

-0.19%

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret br

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-3% return in May, 1% avg return in past 3 year May month.

4% return in 2026, -22% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
266%5%2%-6%-3%4%
25-1%0%-4%-4%-3%3%-4%6%3%-5%4%-3%-8%
24-6%-2%4%-8%9%-2%9%-6%1%-2%-8%2%-10%
23-13%-8%0%-4%-3%-4%-1%-1%-7%-7%0%-1%-49%
22-10%-11%11%-6%11%-1%-3%-10%-3%5%4%2%-10%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 29/100

Bearish · Downtrend · Neutral

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$148.21B

P/E ratio

19.85

52W high

$28.75

52W low

$23.06

Volume

1,74,76,677

Beta

0.30

Related stocks in Healthcare

Frequently asked questions

What is Pfizer Inc. share price today?
Pfizer Inc. (PFE) last traded around $25.90 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does PFE have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PFE. Download the app for real-time alerts.
How can I analyze Pfizer Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro